Viewing Study NCT06609850

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:20 PM
Ignite Modification Date: 2026-06-04 @ 7:47 PM
Study NCT ID: NCT06609850
Status: RECRUITING
Last Update Posted: 2024-12-03
First Post: 2024-09-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma
Sponsor: Sun Yat-sen University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Recurrent Hepatocellular Carcinoma View
None Lenvatinib View
None Local Therapy View
None Ablation View
None Systemic Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lenvatinb View
None Hepatocellular carcinoma View
None Microwave ablation View
None Radiofrequency ablation View
None Cryoablation View